NCT00460421 2014-12-05A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCTSwedish Orphan BiovitrumPhase 1 Completed27 enrolled 19 charts